4,7,10,13,16,19,22,25,28,31,34-Undecaoxaheptatriaconta-1,36-diyne

 CAS No.: 1351373-48-2  Cat No.: BP-500861  Purity: >95% 4.5  

4,7,10,13,16,19,22,25,28,31,34-Undecaoxaheptatriaconta-1,36-diyne is a poly(ethylene glycol)–like ether linker built from a long sequence of repeating oxyethylene units terminating in two alkyne handles. The extended, flexible oxygen-rich chain provides substantial conformational freedom and aqueous compatibility, while the terminal diyne functionality enables orthogonal chemical conjugation to PROTAC-relevant fragments through alkyne-based coupling strategies (e.g., click-type or related alkyne reactivity) under conditions commonly used for linker assembly. In PROTAC design, such a long, hydrophilic tether is used to tune the effective distance and relative orientation between the targeting ligand and the E3 ligase–binding moiety, thereby improving formation of the ternary complex and supporting efficient ubiquitination-mediated degradation. This linker is valuable for researchers seeking modular synthesis of targeted protein degraders where linker length, polarity, and attachment geometry are key variables to optimize potency and selectivity.

4,7,10,13,16,19,22,25,28,31,34-Undecaoxaheptatriaconta-1,36-diyne

Structure of 1351373-48-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
PROTAC Linker
Molecular Formula
C26H46O11
Molecular Weight
534.64
Appearance
Pale Yellow or Colorless Oily Liquid

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Purity
>95%
Appearance
Pale Yellow or Colorless Oily Liquid
Storage
Store at 2-8°C
Shipping
Room temperature in continental US; may vary elsewhere.
IUPACName
3-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]prop-1-yne
Synonyms
Bis-propargyl-PEG11; Bis-propargyl-PEG10
Boiling Point
562.1±45.0°C (Predicted)
Density
1.079±0.06 g/cm3 (Predicted)
InChI Key
YGYWDYNYLJLYTA-UHFFFAOYSA-N
InChI
InChI=1S/C26H46O11/c1-3-5-27-7-9-29-11-13-31-15-17-33-19-21-35-23-25-37-26-24-36-22-20-34-18-16-32-14-12-30-10-8-28-6-4-2/h1-2H,5-26H2
SMILES
C#CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCC#C
1. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
NCD Risk Factor Collaboration (NCD-RisC) Lancet. 2016 Apr 2;387(10026):1377-1396.doi: 10.1016/S0140-6736(16)30054-X.
Background:Underweight and severe and morbid obesity are associated with highly elevated risks of adverse health outcomes. We estimated trends in mean body-mass index (BMI), which characterises its population distribution, and in the prevalences of a complete set of BMI categories for adults in all countries.
2. Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis
Zachary J Madewell, Yang Yang, Ira M Longini Jr, M Elizabeth Halloran, Natalie E Dean Meta-AnalysisJAMA Netw Open. 2020 Dec 1;3(12):e2031756.doi: 10.1001/jamanetworkopen.2020.31756.
Importance:Crowded indoor environments, such as households, are high-risk settings for the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Objectives:To examine evidence for household transmission of SARS-CoV-2, disaggregated by several covariates, and to compare it with other coronaviruses.Data source:PubMed, searched through October 19, 2020. Search terms included SARS-CoV-2 or COVID-19 with secondary attack rate, household, close contacts, contact transmission, contact attack rate, or family transmission.Study selection:All articles with original data for estimating household secondary attack rate were included. Case reports focusing on individual households and studies of close contacts that did not report secondary attack rates for household members were excluded.Data extraction and synthesis:Meta-analyses were done using a restricted maximum-likelihood estimator model to yield a point estimate and 95% CI for secondary attack rate for each subgroup analyzed, with a random effect for each study. To make comparisons across exposure types, study was treated as a random effect, and exposure type was a fixed moderator. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline was followed.Main outcomes and measures:Secondary attack rate for SARS-CoV-2, disaggregated by covariates (ie, household or family contact, index case symptom status, adult or child contacts, contact sex, relationship to index case, adult or child index cases, index case sex, number of contacts in household) and for other coronaviruses. Results:A total of 54 relevant studies with 77 758 participants reporting household secondary transmission were identified. Estimated household secondary attack rate was 16.6% (95% CI, 14.0%-19.3%), higher than secondary attack rates for SARS-CoV (7.5%; 95% CI, 4.8%-10.7%) and MERS-CoV (4.7%; 95% CI, 0.9%-10.7%). Household secondary attack rates were increased from symptomatic index cases (18.0%; 95% CI, 14.2%-22.1%) than from asymptomatic index cases (0.7%; 95% CI, 0%-4.9%), to adult contacts (28.3%; 95% CI, 20.2%-37.1%) than to child contacts (16.8%; 95% CI, 12.3%-21.7%), to spouses (37.8%; 95% CI, 25.8%-50.5%) than to other family contacts (17.8%; 95% CI, 11.7%-24.8%), and in households with 1 contact (41.5%; 95% CI, 31.7%-51.7%) than in households with 3 or more contacts (22.8%; 95% CI, 13.6%-33.5%).Conclusions and relevance:The findings of this study suggest that given that individuals with suspected or confirmed infections are being referred to isolate at home, households will continue to be a significant venue for transmission of SARS-CoV-2.
3. Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
Nobuya Inagaki, Masakazu Takeuchi, Tomonori Oura, Takeshi Imaoka, Yutaka Seino Clinical TrialLancet Diabetes Endocrinol. 2022 Sep;10(9):623-633.doi: 10.1016/S2213-8587(22)00188-7.Epub 2022 Jul 30.
Background:As the disease progresses, many patients with type 2 diabetes have difficulty in reaching treatment goals. We aimed to assess the efficacy and safety of tirzepatide, a novel GIP and GLP-1 receptor agonist, compared with dulaglutide in Japanese patients with type 2 diabetes.

This PROTAC linker, 4,7,10,13,16,19,22,25,28,31,34-Undecaoxaheptatriaconta-1,36-diyne, is designed to provide a rigid, extended molecular scaffold that can span distances between a targeting ligand and an E3 ligase-recruiting moiety. Its polyether character supports conformational flexibility while the diyne functionality enables robust, chemistry-compatible attachment strategies commonly used in targeted protein degradation workflows. Detailed structural and reactivity considerations are provided below to guide experimental design.

Structure: The linker contains multiple ether linkages that impart polarity and segmental flexibility, along with two alkyne units that serve as defined reactive handles. Its structure supports an extended, low-steric scaffold with conjugated unsaturation suitable for bond-forming transformations under standard organic synthesis conditions.

Reactivity: The terminal alkyne motifs are compatible with coupling and click-type bond formation approaches used to assemble PROTACs, including alkyne–electrophile conjugations and alkyne-enabled cycloaddition chemistry. Typical preparations rely on inert atmospheres, dry polar aprotic solvents, and base or catalyst systems appropriate to the chosen coupling manifold. Mechanistically, bond formation proceeds via activation of the alkyne π-system or formation of a reactive intermediate that links the linker to complementary functional groups on ligands.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code
Inquiry Basket